Online Inquiry
Cat.#: ACPP-1328
| Despition | MRAP2 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1042 | Recombinant Human BACE1 Protein (6×His Tag) (AC1042) | 50 µg | inquiry |
| ACPP-1397 | Human RNLS Protein (AC1397) | 5 µg | inquiry |
| ACPP-1220 | ELOVL4 Blocking Peptide (AC1220) | 250 µg | inquiry |
| ACPP-1150 | Synthetic Nanodisc Human TRPV1 Protein (AC1150) | 10 µg | inquiry |
| ACPP-1613 | Human RAB3IL1 Protein (AC1613) | 2 µg | inquiry |
| ACPP-1158 | Synthetic Nanodisc Human MC4-R Protein (AC1158) | 10 µg | inquiry |
| ACPP-1118 | Human Insulin (Active) (AC1118) | 25 mg | inquiry |
| ACPP-1190 | ADCY6 Blocking Peptide (AC1190) | 250 µg | inquiry |
| ACPP-1594 | Human CCM2 Protein (AC1594) | 2 µg | inquiry |
| ACPP-1777 | Human Acrp30 Protein (AC1777) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.